Atlas Trials

RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Clinical trial NCT06495307 · TERMINATED

Trial details

NCT number
NCT06495307
Sponsor
Lubris Bio Pty Ltd
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ocular Graft-versus-host Disease
Start date
2025-02-14
Primary completion
2025-03-22
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.